Current and historical daily PE Ratio for RARE (
Ultragenyx Pharmaceutical Inc
) from 2014 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ultragenyx Pharmaceutical stock (RARE) PE ratio as of Apr 25 2024 is 0.
More Details
Ultragenyx Pharmaceutical Inc (RARE) PE Ratio (TTM) Chart
Ultragenyx Pharmaceutical Inc (RARE) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Ultragenyx Pharmaceutical PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-04-26 | At Loss | 2024-02-22 | At Loss |
2024-04-25 | At Loss | 2024-02-21 | At Loss |
2024-04-24 | At Loss | 2024-02-20 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
2024-04-12 | At Loss | 2024-02-07 | At Loss |
2024-04-11 | At Loss | 2024-02-06 | At Loss |
2024-04-10 | At Loss | 2024-02-05 | At Loss |
2024-04-09 | At Loss | 2024-02-02 | At Loss |
2024-04-08 | At Loss | 2024-02-01 | At Loss |
2024-04-05 | At Loss | 2024-01-31 | At Loss |
2024-04-04 | At Loss | 2024-01-30 | At Loss |
2024-04-03 | At Loss | 2024-01-29 | At Loss |
2024-04-02 | At Loss | 2024-01-26 | At Loss |
2024-04-01 | At Loss | 2024-01-25 | At Loss |
2024-03-28 | At Loss | 2024-01-24 | At Loss |
2024-03-27 | At Loss | 2024-01-23 | At Loss |
2024-03-26 | At Loss | 2024-01-22 | At Loss |
2024-03-25 | At Loss | 2024-01-19 | At Loss |
2024-03-22 | At Loss | 2024-01-18 | At Loss |
2024-03-21 | At Loss | 2024-01-17 | At Loss |
2024-03-20 | At Loss | 2024-01-16 | At Loss |
2024-03-19 | At Loss | 2024-01-12 | At Loss |
2024-03-18 | At Loss | 2024-01-11 | At Loss |
2024-03-15 | At Loss | 2024-01-10 | At Loss |
2024-03-14 | At Loss | 2024-01-09 | At Loss |
2024-03-13 | At Loss | 2024-01-08 | At Loss |
2024-03-12 | At Loss | 2024-01-05 | At Loss |
2024-03-11 | At Loss | 2024-01-04 | At Loss |
2024-03-08 | At Loss | 2024-01-03 | At Loss |
2024-03-07 | At Loss | 2024-01-02 | At Loss |
2024-03-06 | At Loss | 2023-12-29 | At Loss |
2024-03-05 | At Loss | 2023-12-28 | At Loss |
2024-03-04 | At Loss | 2023-12-27 | At Loss |
2024-03-01 | At Loss | 2023-12-26 | At Loss |
2024-02-29 | At Loss | 2023-12-22 | At Loss |
2024-02-28 | At Loss | 2023-12-21 | At Loss |
2024-02-27 | At Loss | 2023-12-20 | At Loss |
2024-02-26 | At Loss | 2023-12-19 | At Loss |
2024-02-23 | At Loss | 2023-12-18 | At Loss |
Ultragenyx Pharmaceutical Inc (RARE) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Ultragenyx Pharmaceutical Inc
NAICS : 325412
SIC : 2834
ISIN : US90400D1081
Description